EUVIMEDEUVIMED entdecken
Crossref

Investigation of Galangin against Gastric Cancer through PI3K/AKT/mTOR Signaling Pathway Modulation

Yingzi Wu, Jinhai Luo, Jincan Luo, Bincheng Han, Baojun Xu

Journal of Agricultural and Food Chemistry · 16.11.2026

DOI: 10.1021/acs.jafc.6c06698 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Agricultural and Food Chemistry, online erschienen am 16.11.2026. Verfasst von Yingzi Wu und 4 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben. Gefördert von: Department of Education of Guangdong Province.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastric cancer (GC) therapies are limited by severe adverse effects. Galangin, a natural flavonoid from galangal, shows anticancer activity, but its efficacy and mechanisms against GC remain incompletely defined. We evaluated galangin against GC in vitro and in vivo, focusing on PI3K/AKT/mTOR signaling. Galangin inhibited proliferation and migration of SNU719 and MKN45 cells while sparing GES-1 epithelial cells. In xenografts, galangin (60–120 mg/kg/day) significantly and dose-dependently suppressed tumor growth. Galangin elevated intracellular reactive oxygen species (ROS), reduced mitochondrial membrane potential, and triggered caspase-3 activation and mitochondrial apoptosis. Transcriptomic and network pharmacology analyses implicated PI3K/AKT/mTOR, apoptosis, cell cycle, and p53 pathways; immunoblotting and immunohistochemistry confirmed pathway inhibition in cells and tumors, respectively. These findings support galangin as a multitarget anti-GC candidate with a favorable safety profile relative to 5-FU.

Förderung

  • Department of Education of Guangdong Province

Zitieren

APA

Wu, Y., Luo, J., Luo, J., Han, B., & Xu, B. (2026). Investigation of Galangin against Gastric Cancer through PI3K/AKT/mTOR Signaling Pathway Modulation. Journal of Agricultural and Food Chemistry. https://doi.org/10.1021/acs.jafc.6c06698

Vancouver

Wu Y, Luo J, Luo J, Han B, Xu B. Investigation of Galangin against Gastric Cancer through PI3K/AKT/mTOR Signaling Pathway Modulation. Journal of Agricultural and Food Chemistry. 2026. doi:10.1021/acs.jafc.6c06698

BibTeX
@article{Wu2026,
  author = {Wu, Yingzi and Luo, Jinhai and Luo, Jincan and Han, Bincheng and Xu, Baojun},
  title = {Investigation of Galangin against Gastric Cancer through PI3K/AKT/mTOR Signaling Pathway Modulation},
  journal = {Journal of Agricultural and Food Chemistry},
  year = {2026},
  doi = {10.1021/acs.jafc.6c06698}
}
Kostenlos starten →